HIF1A and breast carcinoma: In summary, a hypothetical model of RBCK1 modulating the HIF1α signaling mechanism in ER+ breast cancer: RBCK1 can interact with the HIF1α protein to indirectly inhibit its polyubiquitination and degradation at K48 site, thereby promoting HIF1α target gene expression as well as breast cancer progression.